Early Combination Therapy With SGLT2 Inhibitors and GLP-1 Receptor Agonists or Dual GIP/GLP-1 Receptor Agonists in Individuals With Type 2 Diabetes
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Early combination therapy with SGLT2i and GLP-1 RA or dual GIP/GLP-1 RA in type 2 diabetes
Diabetes Obes Metab 2024 Nov 27;[EPub Ahead of Print], C Vale, IM Lourenço, G Jordan, I Golovaty, H Torres, T Moin, M Buysschaert, JS Neves, M BergmanFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.